The PlexusDx Precision Peptide Genetic Test ($298) identifies your genetic predispositions in appetite-control pathways, revealing whether semaglutide, tirzepatide, or a dual-compound protocol will likely work best for your biology
Injecting into muscle rather than fat may lead to greater pain, irritation and faster absorption
Second Implication The second implication involves the relationship between insulin injection sites and exercise-induced blood flow
The PlexusDx Precision Peptide Genetic Test can help provide pathway-level context (it does not predict your response)
Related Stories Generic semaglutide could improve diabetes treatment affordability in Canada New home test uses thigh length to detect type 2 diabetes or prediabetes Newer GLP-1 medications may reduce alcohol-related hospitalization risk Tirzepatide is being studied in the Study of Tirzepatide in Pediatric Participants with Type 2 Diabetes (SURPASS-PEDS) trial for children and adolescents with type 2 diabetes and the SURPASS-2 trial for those with obesity or overweight and related comorbidities
In clinical trials, people on the drugs ended up with lower blood pressure, blood sugar, and cholesterol, and some studies suggest the meds could treat fatty liver disease, too